Keeping One Step Ahead.
Followers | 127 |
Posts | 7,213 |
Boards Moderated | 1 |
Alias Born | 04/15/2010 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Time to move ont his $GDHG . 99% down ... $5 would be 80% down. BUT ....1950% UP FROM HERE.....CLICK,CLICK, the BUY NOW . This is my gut feeling , based on a great... IRISH BREAKFAST.
$RONN .25 buys / 27 sells today, 64% retrace from 450% run , Reset for Monday underway . Holding 100 - 150% gain for week,Friday ,negativity, a little dillution , some bashing . All is good.
Can we burn the Hindenburg, money adoring , prostitute liars , and do the world a favor. during solar eclipse , Monday Powerhour.$GDHG .
Let's Roll.
UNDER TIGHT CONTROL , untill the ,HOT AIR BALLOON , people are loaded. to drive it back up, Double killing for Hindenburg on the way.
You are losing a "zero' for that post . Good one Max.
Tomorrow's , 1 for 40 reverse split is keeping this in check ,imo.
But should open close to $6 ..in the morning. THEN ??????
$RDHL...
.plans to implement a ratio change of the Company’s American Depositary Shares (ADSs) to its non-traded ordinary shares from the current ratio of one (1) ADS representing ten (10) ordinary shares to a new ratio of one (1) ADS representing four hundred (400) ordinary shares. The anticipated first date of the ratio change is on or about March 23, 2023,
$AMV in a very money hungry business , they need to sell more shares ,seems like .$ 13 MIL .not enough for new plans . Anybody else selling is a loser for sure .
Allmost 40 mil. on nasdaq . AMV. Selling the news "till 4:00 . NOW ??.. $AMV
$AIAD . TERMINATE SELLING NOW OR FACE THE TERMINATOR. AI'LL BE BOCK.
Ask stacker WINNING. $AIAD.
Some do not want to let the baby walk up the RED HILL. $RDHL
Little more buys than sells , still they sink the pps . Something is ROTTEN within this system , CITADEL POSTED 16 billion $$$$$$$$$$s. profit a few days ago . WHITE HOUSE ATTACKS ,OIL CO. PROFITS ????????,. OVERHAUL NEEDED. $HLBZ
SEPT 21- 2021 - $41.88 . SPIKE . $HLBZ .
Since all buys were sold ,and all sells were bought ,the opposite is also logical. $IGEX is a WINNER
ROBERT ICEBERG IS STEERING THIS SHIP. N.S.E.W .? direction.
$LCLP. LOST .
Going to be close, only about 2 days GRACE to go . imo. Probably too late anyway as nothing will be moving
in the REGULATORY DEPT. . FROM FRIDAY TO TUESDAY . $LCLP . Digging a bigger hole to climb out of .
Corrupt management can use SEC rules (designed to PROTECT SHAREHOLDERS , HUH) to take a company with great prospects PRIVATE , after suspension and revocation . Operations continue without the
hinderance of pesky shareholder whose money is now ,COMPANY'S. THE END . I am wary of CEO's who wear ROSE colored sunglasses. $LCLP.
$LCLP Is now in a 15 day "GRACE PERIOD " before downgrade to EXPERT MARKET , per OTC Markets
Limited Information Icon
Pink Limited Information
Grace Period IconGrace Period..************************************
Delinquent SEC Reporting IconDelinquent SEC Reporting
Transfer Agent Verified IconTransfer Agent Verified
https://www.otcmarkets.com/stock/LCLP/overview
Grace Period
This security has entered a Grace Period, where it can be publicly quoted for 15 days before moving to the Expert Market for unsolicited quoting only. Securities enter the Grace Period when OTC Markets Group is no longer able to confirm that the issuer’s disclosure is current and publicly available as required under Rule 15c2-11.
More buys than sells by a little .but still dropping , yesterday was also buy positive. where are the shares coming from. WHO IS THE GRINCH. $COSM
ONLY 3,351.000 O/S NOW .......... https://www.otcmarkets.com/stock/COSM/security...$cosm
You speak , cawcaw, caw,caw, hahahaw $cosm
The trouble now is ,eventhough it is getting interesting to buy heavy in trips , SOON, the little moron will R/S ON US AFTER ROBBING US ,the Robert way,. $LCLP. It's only business.
For sure, and if that "management " believes the stock is only worth .001 ,then we are going there or below there .since they are optimistic about that price, imo. $LCLP
So they're going to merge 2 shells, and call it a cucoon ,FINRA ,willing? TH, Tally HO. folks . ATYG . The mystery deepens.
The Machine is learning how to print more dilution. Ah. A.I. KNOW. $GTCH, GET THE CASH HOME.
BRING ON ,MOJO MOJO mojo. $RGBP
100 X .. $RGBP
$RGBP ...100% COPPER NOW.
YEA ,LET'S MOVE IT , and leave the stalkers STUMPED $RGBP
NEW BASE for next SURGE .Still 150% over LOY. Good predicament here for more upside. $RGBP
BUT. WHAT IF THIS PANS OUT POSITIVE
Novel Means of Leveraging Cellular Therapy to "Teach" Immune System to Seek and Destroy Cancer
SAN DIEGO, July 26, 2022 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), announced today the filing with the United States Patent and Trademark Office of a provisional patent application covering utilization of dendritic cell technologies to augment efficacy of its patented survivin mRNA cancer immunotherapeutic vaccine.
In 2021 the Company was granted US patent # 11,090,332 on composition of matter of survivin modified-mRNA useful for teaching the immune system to kill cancer. In the current patent, specific types of dendritic cells, means of generating specialized dendritic cells, and the planned formulation that will enter clinical trials have been granted patent protection.
"We are proud of our collaborators and colleagues who have worked on our first issued survivin patent, which was filed in 2015, before the world realized the potency of modified-mRNA technology that was first successfully commercialized with the COVID-19 vaccines by Moderna and Pfizer," said Dr. David Koos, CEO and Chairman of the Company. "The currently filed application discloses means of significantly increasing efficacy by combining modified-mRNA with unique cellular immunotherapy as well as adjuvant approaches. We chose this strategy to maximally protect our intellectual property around this potentially very valuable mRNA cancer immunotherapy vaccine."
Immunotherapy of cancer represents a very large market which is currently being led by the class of drugs called "checkpoint inhibitors" and "CAR-T" cells. To date there is no mRNA immunotherapy available for treating cancer. This patent application protects the use of our patented survivin mRNA both as a stand-alone vaccine and as an immunotherapy.
About Regen BioPharma Inc.:
Regen BioPharma, Inc. is a publicly traded biotechnology company (PINK: RGBP) and (PINK: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on mRNA and small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.
Disclaimer: This news announcement may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
CONTACT INFORMATION
Regen BioPharma Inc.
David R. Koos, Ph.D.
Chairman & Chief Executive Officer
+1-619-722-5505 Phone
+1-619-330-2328 Fax
http://www.regenbiopharma.com
david.koos@regenbiopharma.com
Follow us on Twitter for future updates: https://twitter.com/TheRegenBio
View original content:https://www.prnewswire.com/news-releases/regen-biopharma-inc--files-provisional-patent--application-on-second-generation-survivin-mrna-cancer-immunotherapy-vaccine-301593795.html
SOURCE Regen BioPharma, Inc.
> Dow Jones Newswires
July 26, 2022 17:14 ET (21:14 GMT)
He sure as HEEL not being nice to his loyal supporters, for whom he was so grateful last week ??????? $RDAR, Time to bring on BALDY, we need a win.
$RDAR killed the RAADR STAR...........
Don't be too harsh on them J, they do have many irons in the fire ,just the fire is really weak right now , it will heat up when BTC gets its feet again after this rout. It obviously takes alot of dollars to stay afloat with leased offices in 5 or 6 countries scattered around the globe . imo.
I hope they do not scuttle the ship though . $LCLP
Nothing going to happen "til we get some super numbers next filing. (IF ANY GOOD NEWS EVER COMES) But world travel,hotels ,meals, + big salaries are a major drag .? $LCLP
$LCLP, ALL GAPS FILLED , NOW WE GO DOWN. YIPPEE, ;iceberg,
AXEMAN, like to cut tree of LIFECLIPS down. yea? $LCLP
For every seller there wAs a buyer in the teens , some people accumulated , some got duped . With an M/C under $4 MIL . IT JUST SEEMED TOO CHEAP. split or not. $LCLP. 100 mil vol in 20 minutes . LETS GO . These guys were busy and real quiet for a month . sumptins UP. or comming.
Looking promising here for a change , can we say double today . $LCLP